Clinical Overview

Neonatal acne appears in 20% of newborns within first 2-4 weeks of life, representing normal physiologic response to maternal androgens rather than pathologic acne. Also known as neonatal cephalic pustulosis when Malassezia-associated, the condition is transient and self-limited. Most cases resolve spontaneously within 2-4 months without intervention, causing no long-term sequelae or scarring.

Epidemiology

Neonatal acne affects 20% of newborns, making it one of most common neonatal skin conditions. Males affected more frequently than females (male-to-female ratio approximately 5:3) due to higher androgen sensitivity. Neonatal cephalic pustulosis occurs in similar frequency. No association with seborrheic dermatitis or atopy. Slight increased risk with family history of severe acne.

Pathophysiology

Neonatal acne results from perioral sebaceous gland stimulation by maternal androgens in utero (primarily dihydrotestosterone). At birth, glands remain stimulated as maternal hormone levels exceed neonatal production. Follicular obstruction combined with androgen-stimulated sebaceous secretion creates comedones and inflammatory pustules. Neonatal cephalic pustulosis may involve Malassezia furfur colonization of follicles, causing folliculitis rather than true acne.

Clinical Presentation

1-3 mm red pustules with occasional inflammatory papules or small nodules. Typical distribution: cheeks, forehead, chin, perioral and perinasal areas. Black or white comedones may be present. Non-pruritic and non-painful. Appears within 2-4 weeks of birth, rarely persists beyond 3-4 months. Scarring does not occur. Secondary bacterial infection is rare.

Diagnosis

Clinical diagnosis based on timing (within first 4 weeks), characteristic distribution (face, perioral), and appearance (small pustules). Differentiate from infantile acne (onset 2-3 months). KOH preparation or fungal culture may identify Malassezia furfur if neonatal cephalic pustulosis suspected. Biopsy rarely needed but shows follicular plugging with neutrophilic inflammation.

Treatment (Age-Specific)

Newborns (0-4 weeks): Observation is primary approach as most resolve spontaneously within 2-4 months. Gentle cleansing with mild soap and water twice daily. Avoid irritating products including salicylic acid (penetrates neonatal skin more readily) and benzoyl peroxide (systemic absorption risk).

Infants (4 weeks - 3 months) with persistent lesions: Topical azelaic acid 20% lotion/cream applied twice daily is effective and safe, addressing bacterial colonization and inflammation. Alternative: clindamycin 1% lotion once or twice daily. Ketoconazole 2% cream twice daily if Malassezia suspected.

Infants (3+ months) with persistent/worsening lesions: Benzoyl peroxide 2.5% wash, rinsed after 5-10 minutes, once daily or every other day (lower systemic absorption risk in older infants). Mild topical retinoids: tretinoin 0.025% cream at bedtime 2-3 nights weekly for resistant cases. Monitor for excessive drying or sensitization.

Prognosis

Excellent prognosis with 90% spontaneous resolution by 3-4 months. No scarring occurs. Residual erythema may persist for weeks after lesion resolution. Vast majority do not progress to infantile acne. Children with neonatal acne do not show increased risk of severe adolescent acne. Reassurance of parents is critical component of management.

When to See a Pediatric Dermatologist

Most cases managed by primary care physicians with reassurance. Referral appropriate if lesions persist beyond 4-5 months, worsen significantly despite conservative management, show secondary bacterial infection signs, or parents significantly distressed. Specialists can confirm diagnosis and provide treatment recommendations.

FAQ

Q: Is neonatal acne contagious or caused by poor hygiene?
A: No, neonatal acne is not contagious and not hygiene-related. It results from sebaceous gland stimulation by maternal hormones transferred during pregnancy. This is normal physiologic response in 20% of healthy newborns, not reflecting poor parenting.

Q: Will neonatal acne leave permanent scars?
A: No, neonatal acne does not cause scarring. Pustules are superficial and resolve without lasting skin changes. Some temporary redness or pigmentation changes may fade over time, but permanent scarring does not occur.

Q: What can I do at home?
A: Wash baby's face once or twice daily with mild soap and water, then pat dry gently. Avoid harsh products, irritants, or excessive rubbing. Do not squeeze or pick at lesions. Most resolve spontaneously within 2-4 months without treatment. Avoid heavy lotions or oils.

Q: Will this develop into severe acne later?
A: No, neonatal acne does not predict future severe acne. Infants with neonatal acne show no increased risk of adolescent acne. Neonatal acne is temporary, benign condition with no lasting effects on future skin health.

References

  1. Lucky AW. Transient benign skin lesions in newborn. Clin Dermatol. 2012;30(3):276-283.
  2. Williams HC, Dellavalle RP, Garner S. Acne vulgaris. Lancet. 2012;379(9813):361-372.
  3. Rapp DA, Hsu S. Neonatal pustulosis and Malassezia. Pediatr Dermatol. 2003;20(3):184-201.
  4. Niamba P, Weill FX, Sarlangue J, et al. Malassezia furfur in neonatal acne. Arch Dermatol. 1998;134(8):995-998.
  5. Paller AS, Jaworski JC. Neonatal erythroderma. Arch Dermatol. 1993;129(2):166-169.
  6. Fogel BL, Hammersley JR. Atopic dermatitis in childhood. Pediatr Ann. 2011;40(10):500-506.
  7. James WD, Berger TG, Elston DM. Andrews' Diseases. 12th ed. Elsevier; 2016.
  8. Thiboutot D, Gollnick H, Bettoli V, et al. Acne management guidelines. J Am Acad Dermatol. 2013;69(5):e1-e14.
  9. Del Rosso JQ, Webster GF, Jackson JM, et al. Doxycycline for acne. J Am Acad Dermatol. 2007;56(5):791-802.
  10. Collier CN, Harper JC, Cantrill WA, et al. Acne prevalence in adolescents. Adolesc Med. 2008;19(3):575-590.